Safety and efficacy of fecal microbiota transplantation in functional gastrointestinal disorders

Safety and efficacy of fecal microbiota transplantation in functional gastrointestinal disorders - Fecal microbiota transplantation in functional gastrointestinal disorders

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014617

Enrollment

Registered

2014-07-23

Start date

2014-07-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel syndrome, Functional constipation, Functional diarrhea

Interventions

Administration of feces obtained from healthy donors to patients.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with irritable bowel syndrome, functional constipation, functional diarrhea which are refractory to medication for more than 1 year. 2. Donors should be patient's spouse or first- or second-degree relatives.

Exclusion criteria

Exclusion criteria: 1. Donors who show abnormal findings to the screening tests including blood and feces.

Design outcomes

Primary

Measure	Time frame
Safety and efficacy of fecal microbiota transplantation in patients with intractable functional gastrointestinal disorders	—

Countries

Japan

Contacts

Public ContactTatsuhiro Masaoka

Keio University School of Medicine Division of Gastroenterology and Hepatology,Department of Internal Medicine

masaoka@z6.keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026